4.3 Article

A Randomized, Double-Blind, Placebo-Controlled Crossover Study of Coenzyme Q10 Therapy in Hypertensive Patients With the Metabolic Syndrome

Related references

Note: Only part of the references are listed.
Letter Geriatrics & Gerontology

DAYTIME SYSTOLIC BLOOD PRESSURE LOAD AND PREVIOUS STROKE PREDICT CARDIOVASCULAR EVENTS IN TREATED OCTOGENARIANS WITH HYPERTENSION

S. S. Andrade et al.

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2010)

Article Peripheral Vascular Disease

Diagnostic thresholds for ambulatory blood pressure monitoring based on 10-year cardiovascular risk

Masahiro Kikuya et al.

BLOOD PRESSURE MONITORING (2007)

Article Nutrition & Dietetics

Concentration response to the coenzyme Q10 supplement Q-Gel in human volunteers

Sarah Molyneux et al.

NUTRITION RESEARCH (2007)

Review Peripheral Vascular Disease

2007 guidelines for the management of arterial hypertension

Giuseppe Mancia et al.

JOURNAL OF HYPERTENSION (2007)

Article Clinical Neurology

Tolerance of high-dose (3,000 mg/day) coenzyme Q10 in ALS

KL Ferrante et al.

NEUROLOGY (2005)

Article Neurosciences

Pilot trial of high dosages of coenzyme Q10 in patients with Parkinson's disease

CW Shults et al.

EXPERIMENTAL NEUROLOGY (2004)

Article Nutrition & Dietetics

Coenzyme Q10 improves blood pressure and glycaemic control:: a controlled trial in subjects with type 2 diabetes

JM Hodgson et al.

EUROPEAN JOURNAL OF CLINICAL NUTRITION (2002)

Article Nutrition & Dietetics

Biochemical functions of coenzyme Q10

FL Crane

JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION (2001)

Article Medicine, General & Internal

Randomized, double-blind, placebo-controlled trial of coenzyme Q10 in isolated systolic hypertension

BE Burke et al.

SOUTHERN MEDICAL JOURNAL (2001)